Regulations.gov document
Exocrine Pancreatic Insufficiency Drug Products for Over-the-Counter Human Use; Tentative…
Notice · FDA-1979-N-0029 · posted Nov 13, 1985
Key facts
| Document ID | FDA-1979-N-0029-0004 |
|---|---|
| Title | Exocrine Pancreatic Insufficiency Drug Products for Over-the-Counter Human Use; Tentative Final Monograph |
| Document type | Notice |
| Subtype | Proposed Guidelines |
| Agency | FDA |
| Docket | FDA-1979-N-0029 |
| Posted | Nov 13, 1985 |
| Federal Register citation | 50 FR 46594 |
| FR document number | 85-22687 |
| CFR | 21 CFR Part 357 |
| Comment period opens | Nov 7, 1985 |
| Comments due | Jan 8, 1986 |
| Effective date | Oct 8, 1985 |
At a glance
- 10–99 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: